Skip to main content

Table 3 Comparison of survivals in different groups who received heart transplantation for primary cardiac sarcoma with or without chemotherapy

From: Survival after heart transplantation for non-metastatic primary cardiac sarcoma

Patients

Survival (mo) median (range), (cases)

Log-rank P value

Neoadjuvant chemotherapy

Yes

No

 

 All

15 (2–84), (n–18)

18 (2–112), (n = 27)

0.210

 Non-angiosarcoma

36 (5–84), (n = 8)

43 (2–112), (n = 22)

0.462

 Grade3

7 (5–37), (n = 6)

15 (2–43), (n = 9)

0.731

Adjuvent chemotherapy

Yes

No

 

 All

15 (5–36), (n = 11)

36 (2–112), (n = 34)

0.088

 Non-angiosarcoma

18 (18–36), (n = 2)

37 (2–112), (n = 28)

0.407

 Grade3

10 (5–18), (n = 5)

16 (2–43), (n = 10)

0.169

  1. Values are presented as median (range)